Skip to main content

Advertisement

Log in

Few fragility fracture patients perceive that their bone health is affected by their comorbidities and medications

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

We examined fragility fracture patients’ perceptions of associations between bone health and other chronic conditions and medications. Awareness of the associations between bone health and these conditions and medications was low. Providers should increase patients’ awareness of these associations in order to minimize the risk of future fracture.

Introduction

Among patients with a fragility fracture presenting with at least one other chronic health condition, we examined (1) perceptions of the association between bone health and their other health conditions, and (2) perceptions of the association between bone health and prescribed medications taken for other health conditions.

Methods

We identified fragility fracture patients presenting to a Canadian urban fracture clinic with at least one self-reported chronic health condition (in addition to bone fragility). In-depth interviews, 60–90 min in duration, were conducted. Our qualitative methodology was informed by saliency analysis.

Results

We interviewed 26 patients (21 females, 5 males) aged 45 to 84 years old. Participants were taking 1–13 medications each and presented with a variety of comorbidities (range 1–7). All participants described at least one condition or medication they were currently taking for which there existed evidence of a negative effect on bone health (increased risk of fracture, bone loss, falling). Two participants perceived a correct association between their other health conditions and compromised bone health, and four participants perceived a correct association between their medications and compromised bone health.

Conclusion

All patients reported a chronic health condition and/or were taking at least one medication that potentially compromised their bone health. Patient awareness of the association between bone health and other health conditions and prescribed medications was low. Health care providers should increase patients’ awareness of the bone health significance of their chronic conditions and medications in order to minimize the risk of future fracture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Morrish DW, Beaupre LA, Bell NR, Cinats JG, Hanley DA, Harley CH, Juby AG, Lier DA, Maksymowych WP, Majumdar SR (2009) Facilitated bone mineral density testing versus hospital-based case management to improve osteoporosis treatment for hip fracture patients: additional results from a randomized trial. Arthritis Rheum 61(2):209–215

    PubMed  Google Scholar 

  2. Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BH, Morrish DW, Maksymowych WP, Steiner IP, Harley CH, Wirzba BJ, Hanley DA, Blitz S, Russell AS (2004) A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med 141(5):366–373

    PubMed  Google Scholar 

  3. Ho C, Cranney A, Campbell A (2006) Measuring the impact of pharmacist intervention: results of patient education about osteoporosis after fragility fracture. Canadian Journal of Hospital Pharmacy 59(4):184–193

    Google Scholar 

  4. Hafez EA, Mansour HE, Hamza SH, Moftah SG, Younes TB, Ismail MA (2011) Bone mineral density changes in patients with recent-onset rheumatoid arthritis. Clinical Medical Insights: Arthritis and Musculoskeletal Disorders 2011(4):87–94

    Google Scholar 

  5. Vestergaard P, Rejnmark L, Mosekilde L (2006) Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int 79:84–94

    CAS  PubMed  Google Scholar 

  6. Wu Q, Liu B, Tonmoy S (2018) Depression and risk of fractures and bone loss: an updated meta-analysis of prospective studies. Osteoporos Int 29(6):1303–1312

    CAS  PubMed  Google Scholar 

  7. Briot K, Geusens P, Em Bultink I, Lems WF, Roux C. Inflammatory diseases and bone fragility. Osteoporosis International 2017;28(12):3301-14

  8. Bolton JM, Morin SN, Majumdar SER, al. e. Association of mental disorders and related medication use with risk for major osteoporotic fractures. JAMA Psychiatry 2017;74(6):641–648

  9. Lee RH, Lyles KW, Colon-Emeric C (2010) A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. Am J Geriatr Pharmacother 8(1):34–46

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Kahlaee HR, Latt MD, Schneider CR (2018) Association between chronic or acute use of antihypertensive class of medications and falls in older adults. A systematic review and meta-analysis. Am J Hypertens 31(4):467–479

    CAS  PubMed  Google Scholar 

  11. Vranken L, Wyers CE, Van der Velde RY et al (2018) Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service. Osteoporos Int 29:397–407

    CAS  PubMed  Google Scholar 

  12. Munson JC, Bynum JPW, Bell J-E, Cantu R, McDonough C, Wang Q, Tosteson TD, Tosteson AN (2016) Patterns of prescription drug use before and after fragility fracture. JAMA Intern Med 176(10):1531–1538

    PubMed  PubMed Central  Google Scholar 

  13. Litwic AE, Compston JE, Wyman A et al (2018) Self-perception of fracture risk: what can it tell us? Osteoporos Int 28(12):3495–3500

    Google Scholar 

  14. Sale JEM, Beaton D, Posen J, Elliot-Gibson V, Bogoch E (2011) Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 22(7):2067–2082

    CAS  PubMed  Google Scholar 

  15. Ganda K, Puech M, Chen JS, Speerin R, Bleasel J, Center JR, Eisman JA, March L, Seibel MJ (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int 24:393–406

    CAS  PubMed  Google Scholar 

  16. Sandelowski M (2000) Whatever happened to qualitative description? Res Nurs Health 23:334–340

    CAS  PubMed  Google Scholar 

  17. Sandelowski M (2010) What’s in a name? Qualitative description revisited. Res Nurs Health 33:77–84

    PubMed  Google Scholar 

  18. Bogoch ER, Elliot-Gibson F, Beaton D, Sale J, Josse R (2017) Fracture prevention in the orthopaedic environment: outcomes of a coordinator-based fracture liaison service. J Bone Joint Surg 99:820–831

    PubMed  Google Scholar 

  19. Bogoch ER, Elliot-Gibson V, Wang RYC, Josse GJ (2012) Secondary causes of osteoporosis in fracture patients. J Orthop Trauma 26(9):e145–ee52

    PubMed  Google Scholar 

  20. Langdridge D. Phenomenological psychology: theory, research and method. Harlow, England: Pearson Prentice Hall, 2007

  21. Davis JC, Guy P, Ashe MC, Liu-Ambrose T, Khan K (2007) HipWatch: osteoporosis investigation and treatment after a hip fracture: a 6-month randomized controlled trial. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 62(8):888–891

    Google Scholar 

  22. Bajcar JM, Wang L, Moineddin R, Nie JX, Tracy CS, Upshur REG (2010) From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997–2006. BMC Fam Pract 11:75–1–75-6

    Google Scholar 

  23. Canada S. A portrait of seniors in Canada. Ottawa, ON, 2006:1–301

  24. Arden NK, Nevitt MC, Lane NE, Gore LR, Hochberg MC, Scott JC, Pressman AR, Cummings SR (1999) Osteoarthritis and risk of falls, rates of bone loss, and osteoporotic fractures. Arthritis Rheum 42(7):1378–1385

    CAS  PubMed  Google Scholar 

  25. NIH Osteoporosis and Related Bone Diseases National Resource Center (2018) What people with asthma need to know about osteoporosis. Bethesda, MD

  26. Kvale S (1996) Interviews: an introduction to qualitative research interviewing. Sage Publications, Thousand Oaks, CA

    Google Scholar 

  27. Crabtree BF, Miller WL (1992) Doing qualitative research. Sage Publications, Newbury Park, CA

    Google Scholar 

  28. Buetow S (2010) Thematic analysis and its reconceptualization as ‘saliency analysis’. Journal of Health Services Research & Policy 15(2):123–125

    Google Scholar 

  29. Sandelowski M (2001) Real qualitative researchers do not count: the use of numbers in qualitative research. Res Nurs Health 24:230–240

    CAS  PubMed  Google Scholar 

  30. Dixon-Woods M, Shaw RL, Agarwal S, Smith JA (2004) The problem of appraising qualitative research. Quality and Safety in Health Care 13:223–225

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Kvale S, Brinkmann S (2009) Interviews: learning the craft of qualitative research interviewing, 2nd edn. Sage Publications Ltd., Thousand Oaks

    Google Scholar 

  32. Sandelowski M (1995) Sample size in qualitative research. Res Nurs Health 18:179–183

    CAS  PubMed  Google Scholar 

  33. Shah VN, Shah CS, Snell-Bergeon JK (2015) Type 1 diabetes and risk of fracture: meta-analysis and review of the literature. Diabet Med 32:1134–1142

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, el-Hajj Fuleihan G, Josse R, Kendler DL, Kraenzlin M, Suzuki A, Pierroz DD, Schwartz AV, Leslie WD, Bone and Diabetes Working Group of IOF (2018) Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int 29(12):2585–2596

  35. Vestergaard P (2005) Epilepsy, osteoporosis and fracture risk—a meta-analysis. Acta Neurol Scand 112(5):277–286

    CAS  PubMed  Google Scholar 

  36. McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, Aldrovandi GM, Cardoso SW, Santana JL, Brown TT (2010) Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis 51(8):937–946

    PubMed  Google Scholar 

  37. Omair MA, Pagnoux C, McDonald-Blumer H, Johnson SR (2013) Low bone density in systemic sclerosis. A systematic review. J Rheumatol 40(1):1881–1890

    PubMed  Google Scholar 

  38. Eimar H, Saltaji H, Ghorashi S et al (2017) Association between sleep apnea and low bone mass in adults: a systematic review and meta-analysis. Osteoporos Int 28:1835–1852

    CAS  PubMed  Google Scholar 

  39. Huang AR, Mallet L, Rochefort CM, Equale T, Buckeridge DL, Tamblyn R (2012) Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging 29(5):359–376

    CAS  PubMed  Google Scholar 

  40. Nguyen KD, Bagheri B, Bagheri H (2018) Drug-induced bone loss: a major safety concern in Europe. Expert Opin Drug Saf 17(10):1005–1014

    CAS  PubMed  Google Scholar 

  41. American Geriatrics Society 2019 Beers Criteria Update Expert Panel (2019) American Geriatrics Society 2019 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 67(4):647–694

  42. Hegeman JH, van den Bemt BJF, Duysens J, van Limbeek J (2009) NSAIDS and the risk of accidental falls in the elderly: a systematic review. Drug Saf 32(6):489–498

    CAS  PubMed  Google Scholar 

  43. Rucker D, Rowe BH, Johnson JA, Steiner IP, Russell AS, Hanley DA, Maksymowych WP, Holroyd BR, Harley CH, Morrish DW, Wirzba BJ, Majumdar SR (2006) Educational intervention to reduce falls and fear of falling in patients after fragility fracture: results of a controlled pilot study. Prev Med 42(4):316–319

    PubMed  Google Scholar 

  44. Yeam CT, Chia S, Tan HCC, Kwan YH, Fong W, Seng JJB (2018) A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int 29:2623–2637

    CAS  PubMed  Google Scholar 

  45. Cristancho P, Lenze EJ, Avidan MS, Rawson KS (2016) Trajectories of depressive symptoms after hip fracture. Psychol Med 46(7):1413–1425

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Zia A, Kamaruzzaman SB, Tan MP (2015) Polypharmacy and falls in older people: balancing evidence-based medicine against falls risk. Postgrad Med 127(3):330–337

    PubMed  Google Scholar 

  47. Dahodwala M, Geransar R, Babion J, de Grood J, Sargious P (2018) The impact of the use of video-based educational interventions on patient outcomes in hospital settings: a scoping review. Patient Educ Couns 101:2116

    PubMed  Google Scholar 

  48. Abed MA, Himmel W, Vormfelde S, Koschack J (2014) Video-assisted patient education to modify behavior: a systematic review. Patient Educ Couns 97:16–22

    PubMed  Google Scholar 

  49. Khan MN, Khan AA (2008) Cancer treatment-related bone loss: a review and synthesis of the literature. Curr Oncol 15(Supplement 1):S30–S40

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Mazziotti G, Canalis E, Giustina A (2010) Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med 123:877–884

    CAS  PubMed  Google Scholar 

  51. Atteritano M, Sorbara S, Bagnato G, Miceli G, Sangari D, Morgante S, Visalli E, Bagnato G (2013) Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PLoS One 8(6):e66991

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

Funding for this project was provided by the Canadian Institutes of Health Research (MOP – 136934). Joanna Sale held a Canadian Institutes of Health Research New Investigator Salary Award (Funding Reference Number COB-136622) at the time the manuscript was submitted.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J.E.M. Sale.

Ethics declarations

Conflicts of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sale, J., Frankel, L., Bogoch, E. et al. Few fragility fracture patients perceive that their bone health is affected by their comorbidities and medications. Osteoporos Int 31, 2047–2055 (2020). https://doi.org/10.1007/s00198-020-05409-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-020-05409-w

Keywords

Navigation